| Literature DB >> 31821350 |
Cristina Martín-Pérez1, Juan F Navas2, José C Perales1,3, Ángela López-Martín4, Sergio Cordovilla-Guardia5, Mónica Portillo6, Antonio Maldonado1,3, Raquel Vilar-López1,7.
Abstract
College students are particularly vulnerable to risky alcohol use, which increases their likelihood of developing an alcohol use disorder in the future. As such, preventing and reducing alcohol use among college students should be a priority for health and social policies. This work was aimed to show that brief group-delivered MI is as effective as brief-group CBT at reducing alcohol use in college students. Eighty-nine college students (69 females; mean age = 21.01, SD = 2.85) with risky alcohol use, as measured by the AUDIT-C, were assigned to two groups, receiving three sessions of either brief group-delivered MI or CBT (bMI/bCBT). Alcohol use was assessed 3 and 6 months after the interventions, and analyzed according to an Intention-to-treat design. Changes in alcohol use at both points (relative to baseline) as well as post-intervention scores of intention to continue treatment and satisfaction with the psychologist were compared across groups, using one-sided Bayesian t-tests. Alcohol use decreased in both groups at the 3- and 6-months measurement points (relative to baseline). However, using bCBT superiority as an alternative hypothesis and the absence of such superiority as a point-null hypothesis, the Bayes factors supported the null at both the 3- and the 6-months follow-up (BF01 = 7.13, and BF01 = 5.22 respectively). Furthermore, the intention to continue treatment was substantially higher in the bMI group (BF10 = 9.77). These results are considerably robust to changes in analyses' priors. This study suggests that bCBT is not more effective than bMI at reducing alcohol use in our college student group (in which females are overrepresented). Additionally, bMI showed higher intention to continue treatment scores. The comparable results of brief and group-delivered CBT and MI interventions in alcohol use reduction allows clinicians to select treatments based on their own skills or preferences without any detriment to efficacy.Entities:
Year: 2019 PMID: 31821350 PMCID: PMC6903743 DOI: 10.1371/journal.pone.0226271
Source DB: PubMed Journal: PLoS One ISSN: 1932-6203 Impact factor: 3.240
Fig 1Flow Diagram of the two groups throughout the different study phases.
Demographics and clinical characteristics of the study groups.
| Baseline | Baseline (participants with follow-up at month 3) | Baseline (participants with follow-up at month 6) | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ITT-bMI (N = 42) M(SD) | ITT-CBT (N = 47) M(SD) | Stat | ITT-bMI (N = 32) M(SD) | ITT-CBT (N = 39) M(SD) | Stat | ITT-bMI (N = 24) M(SD) | ITT-CBT (N = 32) M(SD) | Stat | ||||
| 22.02 (2.71) | 20.1 (2.7) | -3.347 | .001/ 25.48 | 21.56 (2.36) | 19.79 (1.85) | -3.541 | .001/40.50 | 21.63 (2.36) | 19.91 (1.99 | -2.956 | .005/8.84 | |
| 33 (78.6%) | 36 (76.6%) | 0.050 | 0.824 | 27 (84.4%) | 30 (76.9%) | 0.617 | 0.43 | 19 (79.2%) | 25 (78.1%) | 0.009 | .925 | |
| 14.69 (1.85) | 14.85 (2.60) | 0.331 | .741/ 0.23 | 14.78 (1.81) | 14.85 (2.1) | 0.138 | .891/0.25 | 14.42 (1.72) | 14.84 (2.20) | 0.787 | .435/0.35 | |
| 6.19 (1.59) | 6.77 (2.16) | 1.439 | .154/0.61 | 6.19 (1.69) | 6.44 (1.97) | 0.563 | .576/0.30 | 5.96 (1.60) | 6.59 (2.28) | 1.164 | .250/0.48 | |
| Scores 4–7 | 26 (61.9%) | 24 (51.1%) | 20 (62.5%) | 22 (56.4%) | 17 (70.8%) | 17 (53.1%) | ||||||
| Scores >7 | 16 (38.1%) | 23 (48.9%) | 1.059 | .303 | 12 (37.5%) | 17 (43.6%) | 0.270 | .603 | 7 (29.2%) | 15 (46.9%) | 1.803 | .179 |
| 10.48 (4.32) | 11.89 (4.82) | 1.455 | .149/0.56 | 11.28 (4.64) | 11.97 (5.04) | 0.552 | .597/0.29 | 11.0 (3.86) | 11.44 (3.88) | 0.419 | .677/0.29 | |
| AMB | 7.36 (3.88) | 8.62 (3.52) | 1.607 | .112/0.68 | 8.22 (4.03) | 8.46 (3.66) | 0.266 | .791/0.25 | 8.25 (4.02) | 8.59 (3.22) | 0.355 | .724/0.29 |
| STEP | 15.81 (7.36) | 15.79 (5.96) | -0.016 | .988/0.22 | 16.59 (7.42) | 15.46 (6.30) | -0.695 | .489/0.30 | 17.04 (7.38) | 15.13 (5.59) | -1.064 | .294/0.45 |
Note: Between-participants’ differences were evaluated with independent samples t-tests in all cases, except for sex and AUDIT-C where chi-square tests were used. Abbreviations: ITT-bMI/bCBT = intention-to-treat of brief Motivational Interviewing/Cognitive-Behavioral Therapy; Stat = Statistics; p = p-value
*BF10 = Bayes Factor (for continuous variables)
M(SD) = mean (standard deviation)
REC = recognition; AMB = ambivalence.
Fig 2Differences between ITT-bCBT and ITT-bMI groups.
Differences in alcohol use between: A) Baseline assessment and the 3-month follow-up and B) Baseline and the 6-month follow-up. Abbreviations: ITT, Intention-To-Treat; bCBT, brief Cognitive-Behavioral Therapy; bMI, brief Motivational Interviewing; TLFB, Timeline FollowBack, BF10, Bayes Factor.
Fig 3Between-group differences in A) satisfaction with the psychologist and B) Intention to continue treatment. Abbreviations: ITT, Intention-To-Treat; bCBT, brief Cognitive-Behavioral Therapy; bMI, brief Motivational Interviewing; BF10, Bayes Factor.